131 related articles for article (PubMed ID: 11135265)
1. K-ras oncogene mutation in cancer and precancerous lesions of the gallbladder.
Kim SW; Her KH; Jang JY; Kim WH; Kim YT; Park YH
J Surg Oncol; 2000 Dec; 75(4):246-51. PubMed ID: 11135265
[TBL] [Abstract][Full Text] [Related]
2. [K-ras gene mutation in gallbladder carcinoma].
Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O
Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
[TBL] [Abstract][Full Text] [Related]
3. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer.
Kazmi HR; Chandra A; Nigam J; Noushif M; Parmar D; Gupta V
Dig Surg; 2013; 30(3):233-9. PubMed ID: 23838952
[TBL] [Abstract][Full Text] [Related]
5. [Frequency of K-ras mutation in biliary and pancreatic tumors].
Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
[TBL] [Abstract][Full Text] [Related]
6. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer.
Singh MK; Chetri K; Pandey UB; Kapoor VK; Mittal B; Choudhuri G
J Gastroenterol Hepatol; 2004 Aug; 19(8):916-21. PubMed ID: 15242496
[TBL] [Abstract][Full Text] [Related]
7. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
8. K-ras gene mutation in gall bladder carcinomas and dysplasia.
Ajiki T; Fujimori T; Onoyama H; Yamamoto M; Kitazawa S; Maeda S; Saitoh Y
Gut; 1996 Mar; 38(3):426-9. PubMed ID: 8675098
[TBL] [Abstract][Full Text] [Related]
9. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation.
Tomono H; Nimura Y; Aono K; Nakashima I; Iwamoto T; Nakashima N
Am J Gastroenterol; 1996 Jun; 91(6):1211-4. PubMed ID: 8651173
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas.
Sugio K; Kishimoto Y; Virmani AK; Hung JY; Gazdar AF
Cancer Res; 1994 Nov; 54(22):5811-5. PubMed ID: 7954406
[TBL] [Abstract][Full Text] [Related]
11. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas.
Wistuba II; Miquel JF; Gazdar AF; Albores-Saavedra J
Hum Pathol; 1999 Jan; 30(1):21-5. PubMed ID: 9923922
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of K-ras and beta-catenin genes related to O6-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma.
Kohya N; Kitajima Y; Kitahara K; Miyazaki K
Int J Mol Med; 2003 Jan; 11(1):65-9. PubMed ID: 12469220
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability.
Saetta AA; Papanastasiou P; Michalopoulos NV; Gigelou F; Korkolopoulou P; Bei T; Patsouris E
Virchows Arch; 2004 Aug; 445(2):179-82. PubMed ID: 15221372
[TBL] [Abstract][Full Text] [Related]
14. Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts.
Iwase T; Nakazawa S; Yamao K; Yoshino J; Inui K; Yamachika H; Kanemaki N; Fujimoto M; Okushima K; Miyoshi H; Taki N; Nakamura Y; Mizutani S; Horibe Y; Masui T; Tatematsu M
Hepatogastroenterology; 1997; 44(17):1457-62. PubMed ID: 9356872
[TBL] [Abstract][Full Text] [Related]
15. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Tsuchida A; Iwao T; Eguchi N; Sasaki T; Morinaka K; Matsubara K; Kawasaki Y; Yamamoto S; Kajiyama G
Am J Gastroenterol; 1999 Jun; 94(6):1638-42. PubMed ID: 10364037
[TBL] [Abstract][Full Text] [Related]
16. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
17. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
18. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections.
Lee JC; Lin PW; Lin YJ; Lai J; Yang HB; Lai MD
J Formos Med Assoc; 1995 Dec; 94(12):719-23. PubMed ID: 8541732
[TBL] [Abstract][Full Text] [Related]
19. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
Dieterle CP; Conzelmann M; Linnemann U; Berger MR
Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
[TBL] [Abstract][Full Text] [Related]
20. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]